{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:56:35Z","timestamp":1780491395658,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyper-homocysteinemia (HHcy) is associated with microalbuminuria and glomerular injury in general and diabetic populations. However, HHcy\u2019s role in hypertensive patients was not studied. We investigated whether HHcy is an independent risk factor for renal function decline and development of chronic kidney disease (CKD) in hypertensive men and women. This was a community-based prospective cohort study of 2,387 hypertensive adults without CKD at baseline, with a mean follow-up of 4.4 years. Baseline and follow-up levels of plasma Hcy, folate, vitamin B12, blood pressure and other pertinent covariables were obtained. CKD was defined as an estimated glomerular filtration rate (eGFR) &lt;60\u2009ml\/min\/per 1.73\u2009m<jats:sup>2<\/jats:sup> and an eGFR decline rate &gt;1\u2009ml\/min\/per 1.73\u2009m<jats:sup>2<\/jats:sup>\/year. There was a graded association between Hcy tertiles and eGFR decline. Subjects in the 3<jats:sup>rd<\/jats:sup> tertile of Hcy levels had an accelerated rate of eGFR decline and an increased risk of incident CKD, as compared with those in the 1st tertile, after adjusting for age, gender, baseline diabetes, SBP, BMI, smoking, dyslipidemia, eGFR, folate and vitamin B12 levels. In conclusion, in this prospective cohort of Chinese hypertensive adults, elevated baseline plasma Hcy can serve as an independent biomarker to predict renal function decline and incident CKD.<\/jats:p>","DOI":"10.1038\/srep16268","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T10:15:24Z","timestamp":1447150524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults"],"prefix":"10.1038","volume":"5","author":[{"given":"Di","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genfu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangpu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"BFsrep16268_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038\u20132047 (2007).","journal-title":"JAMA"},{"key":"BFsrep16268_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2458-8-117","volume":"8","author":"QL Zhang","year":"2008","unstructured":"Zhang, Q. L. & Rothenbacher, D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8, 117 (2008).","journal-title":"BMC Public Health"},{"key":"BFsrep16268_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379, 815\u2013822 (2012).","journal-title":"Lancet"},{"key":"BFsrep16268_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/archinte.165.8.923","volume":"165","author":"CY Hsu","year":"2005","unstructured":"Hsu, C. Y., McCulloch, C. E., Darbinian, J., Go, A. S. & Iribarren, C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165, 923\u2013928 (2005).","journal-title":"Arch Intern Med"},{"key":"BFsrep16268_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","volume":"41","author":"M Tozawa","year":"2003","unstructured":"Tozawa, M. et al. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 41, 1341\u20131345 (2003).","journal-title":"Hypertension"},{"key":"BFsrep16268_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103","volume":"334","author":"MJ Klag","year":"1996","unstructured":"Klag, M. J. et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334, 13\u201318 (1996).","journal-title":"N Engl J Med"},{"key":"BFsrep16268_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","volume":"44","author":"T Ninomiya","year":"2004","unstructured":"Ninomiya, T. et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis 44, 437\u2013445 (2004).","journal-title":"Am J Kidney Dis"},{"key":"BFsrep16268_CR8","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1681\/ASN.2010010085","volume":"21","author":"CS Fox","year":"2010","unstructured":"Fox, C. S. et al. A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol 21, 2143\u20132149 (2010).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep16268_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.ki.5002031","volume":"71","author":"S Shastry","year":"2007","unstructured":"Shastry, S., Ingram, A. J., Scholey, J. W. & James, L. R. Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase. Kidney Int 71, 304\u2013311 (2007).","journal-title":"Kidney Int"},{"key":"BFsrep16268_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.ki.5001517","volume":"70","author":"F Yi","year":"2006","unstructured":"Yi, F. et al. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int 70, 88\u201396 (2006).","journal-title":"Kidney Int"},{"key":"BFsrep16268_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000090947","volume":"43","author":"AS Sethi","year":"2006","unstructured":"Sethi, A. S., Lees, D. M., Douthwaite, J. A., Dawnay, A. B. & Corder, R. Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells. J Vasc Res 43, 175\u2013183 (2006).","journal-title":"J Vasc Res"},{"key":"BFsrep16268_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000110876","volume":"28","author":"F Yi","year":"2008","unstructured":"Yi, F. & Li, P. L. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol 28, 254\u2013264 (2008).","journal-title":"Am J Nephrol"},{"key":"BFsrep16268_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1050-1738(99)00002-X","volume":"9","author":"ME Lee","year":"1999","unstructured":"Lee, M. E. & Wang, H. Homocysteine and hypomethylation. A novel link to vascular disease. Trends Cardiovasc Med 9, 49\u201354 (1999).","journal-title":"Trends Cardiovasc Med"},{"key":"BFsrep16268_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/1471-2458-11-733","volume":"11","author":"F Marti","year":"2011","unstructured":"Marti, F. et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 11, 733 (2011).","journal-title":"BMC Public Health"},{"key":"BFsrep16268_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/01.ATV.21.1.74","volume":"21","author":"A Jager","year":"2001","unstructured":"Jager, A. et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol 21, 74\u201381 (2001).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep16268_CR16","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1096\/fj.09-143651","volume":"24","author":"NC Chen","year":"2010","unstructured":"Chen, N. C. et al. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J 24, 2804\u20132817 (2010).","journal-title":"FASEB J"},{"key":"BFsrep16268_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst, P. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111\u2013113 (1995).","journal-title":"Nat Genet"},{"key":"BFsrep16268_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1056\/NEJM199502023320511","volume":"332","author":"MJ Stampfer","year":"1995","unstructured":"Stampfer, M. J. & Malinow, M. R. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 332, 328\u2013329 (1995).","journal-title":"N Engl J Med"},{"key":"BFsrep16268_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jama.279.5.359","volume":"279","author":"EB Rimm","year":"1998","unstructured":"Rimm, E. B. et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279, 359\u2013364 (1998).","journal-title":"JAMA"},{"key":"BFsrep16268_CR20","doi-asserted-by":"publisher","first-page":"e65938","DOI":"10.1371\/journal.pone.0065938","volume":"8","author":"Y Gao","year":"2013","unstructured":"Gao, Y. et al. Prevalence of hypertension in china: a cross-sectional study. PLoS One 8, e65938 (2013).","journal-title":"PLoS One"},{"key":"BFsrep16268_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jn\/137.2.407","volume":"137","author":"L Hao","year":"2007","unstructured":"Hao, L. et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12 and vitamin B-6 status. J Nutr 137, 407\u2013413 (2007).","journal-title":"J Nutr"},{"key":"BFsrep16268_CR22","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1093\/jn\/133.11.3630","volume":"133","author":"L Hao","year":"2003","unstructured":"Hao, L. et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr 133, 3630\u20133635 (2003).","journal-title":"J Nutr"},{"key":"BFsrep16268_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/oxfordjournals.aje.a010290","volume":"151","author":"LD Botto","year":"2000","unstructured":"Botto, L. D. & Yang, Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151, 862\u2013877 (2000).","journal-title":"Am J Epidemiol"},{"key":"BFsrep16268_CR24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jama.2015.2274","volume":"313","author":"Y Huo","year":"2015","unstructured":"Huo, Y. et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313, 1325\u20131335 (2015).","journal-title":"JAMA"},{"key":"BFsrep16268_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","volume":"58","author":"V Veeranna","year":"2011","unstructured":"Veeranna, V. et al. Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol 58, 1025\u20131033 (2011).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep16268_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev.nu.12.070192.001431","volume":"12","author":"SS Kang","year":"1992","unstructured":"Kang, S. S., Wong, P. W. & Malinow, M. R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12, 279\u2013298 (1992).","journal-title":"Annu Rev Nutr"},{"key":"BFsrep16268_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00392-004-0075-3","volume":"93","author":"O Stanger","year":"2004","unstructured":"Stanger, O. et al. Clinical use and rational management of homocysteine, folic acid and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 93, 439\u2013453 (2004).","journal-title":"Z Kardiol"},{"key":"BFsrep16268_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2010.07.013","volume":"298","author":"A Towfighi","year":"2010","unstructured":"Towfighi, A., Markovic, D. & Ovbiagele, B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci 298, 153\u2013157 (2010).","journal-title":"J Neurol Sci"},{"key":"BFsrep16268_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-131-5-199909070-00006","volume":"131","author":"AG Bostom","year":"1999","unstructured":"Bostom, A. G. et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 131, 352\u2013355 (1999).","journal-title":"Ann Intern Med"},{"key":"BFsrep16268_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey, C. J., Beresford, S. A., Omenn, G. S. & Motulsky, A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049\u20131057 (1995).","journal-title":"JAMA"},{"key":"BFsrep16268_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1161\/01.CIR.87.4.1107","volume":"87","author":"MR Malinow","year":"1993","unstructured":"Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E. & Bond, G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 87, 1107\u20131113 (1993).","journal-title":"Circulation"},{"key":"BFsrep16268_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard, O. et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337, 230\u2013236 (1997).","journal-title":"N Engl J Med"},{"key":"BFsrep16268_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/A:1005373209964","volume":"20","author":"DE Wilcken","year":"1997","unstructured":"Wilcken, D. E. & Wilcken, B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 20, 295\u2013300 (1997).","journal-title":"J Inherit Metab Dis"},{"key":"BFsrep16268_CR34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1055\/s-0037-1615380","volume":"80","author":"M den Heijer","year":"1998","unstructured":"den Heijer, M., Rosendaal, F. R., Blom, H. J., Gerrits, W. B. & Bos, G. M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80, 874\u2013877 (1998).","journal-title":"Thromb Haemost"},{"key":"BFsrep16268_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald, D. S., Law, M. & Morris, J. K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202 (2002).","journal-title":"BMJ"},{"key":"BFsrep16268_CR36","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","volume":"369","author":"X Wang","year":"2007","unstructured":"Wang, X. et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876\u20131882 (2007).","journal-title":"Lancet"},{"key":"BFsrep16268_CR37","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1161\/01.ATV.0000189559.87328.e4","volume":"25","author":"X Jiang","year":"2005","unstructured":"Jiang, X. et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25, 2515\u20132521 (2005).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep16268_CR38","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1182\/blood-2007-06-096701","volume":"110","author":"MD Jamaluddin","year":"2007","unstructured":"Jamaluddin, M. D. et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 110, 3648\u20133655 (2007).","journal-title":"Blood"},{"key":"BFsrep16268_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/157340209788166940","volume":"5","author":"Z Cheng","year":"2009","unstructured":"Cheng, Z., Yang, X. & Wang, H. Hyperhomocysteinemia and Endothelial Dysfunction. Curr Hypertens Rev 5, 158\u2013165 (2009).","journal-title":"Curr Hypertens Rev"},{"key":"BFsrep16268_CR40","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clnu.2012.12.009","volume":"32","author":"X Qin","year":"2013","unstructured":"Qin, X. et al. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials. Clin Nutr 32, 722\u2013727 (2013).","journal-title":"Clin Nutr"},{"key":"BFsrep16268_CR41","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey, A. S. et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53, 766\u2013772 (2007).","journal-title":"Clin Chem"},{"key":"BFsrep16268_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cccn.2004.02.007","volume":"344","author":"W Junge","year":"2004","unstructured":"Junge, W., Wilke, B., Halabi, A. & Klein, G. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffe method. Clin Chim Acta 344, 137\u2013148 (2004).","journal-title":"Clin Chim Acta"},{"key":"BFsrep16268_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150, 604\u2013612 (2009).","journal-title":"Ann Intern Med"},{"key":"BFsrep16268_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2215\/CJN.07900812","volume":"8","author":"M Madero","year":"2013","unstructured":"Madero, M. et al. Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study. Clin J Am Soc Nephrol 8, 424\u2013433 (2013).","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFsrep16268_CR45","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/ajcn\/69.3.476","volume":"69","author":"ES Ford","year":"1999","unstructured":"Ford, E. S. & Bowman, B. A. Serum and red blood cell folate concentrations, race and education: findings from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 69, 476\u2013481 (1999).","journal-title":"Am J Clin Nutr"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16268","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:19:51Z","timestamp":1672924791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep16268"],"URL":"https:\/\/doi.org\/10.1038\/srep16268","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]},"assertion":[{"value":"7 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16268"}}